NYSE:NVTA - Invitae Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$7.63 +0.17 (+2.28 %)
(As of 05/23/2018 03:26 PM ET)
Previous Close$7.46
Today's Range$7.39 - $7.66
52-Week Range$4.35 - $10.41
Volume61,786 shs
Average Volume691,153 shs
Market Capitalization$486.56 million
P/E Ratio-2.82
Dividend YieldN/A
Beta1.03

About Invitae (NYSE:NVTA)

Invitae logoInvitae Corporation, a genetic information company, processes DNA-containing samples, analyzes information related to patient-specific genetic variation, and generates test reports for clinicians and their patients in the United States, Canada, and internationally. The company's tests include multiple genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders, and other hereditary conditions; proactive health and wellness screening; and preimplantation embryo testing and carrier screening for inherited disorders, prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. It also operates Patient Insights Networks, a platform for collecting, curating, coordinating, and delivering data from patients and clinicians; and CancerGene Connect, an end-to-end platform that is used for the collection, analysis, and management of patient family history information. Invitae Corporation serves patients, healthcare providers, and biopharma and advocacy partners. The company was formerly known as Locus Development, Inc. and changed its name to Invitae Corporation in 2012. Invitae Corporation was founded in 2010 and is headquartered in San Francisco, California.

Receive NVTA News and Ratings via Email

Sign-up to receive the latest news and ratings for NVTA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryN/A
SectorMedical
SymbolNYSE:NVTA
CUSIPN/A
Phone415-374-7782

Debt

Debt-to-Equity Ratio0.60
Current Ratio2.53
Quick Ratio2.53

Price-To-Earnings

Trailing P/E Ratio-2.82
Forward P/E Ratio-3.44
P/E GrowthN/A

Sales & Book Value

Annual Sales$68.22 million
Price / Sales7.52
Cash FlowN/A
Price / CashN/A
Book Value$1.52 per share
Price / Book5.02

Profitability

EPS (Most Recent Fiscal Year)($2.65)
Net Income$-123,380,000.00
Net Margins-154.96%
Return on Equity-127.38%
Return on Assets-68.70%

Miscellaneous

Employees594
Outstanding Shares67,210,000

Invitae (NYSE:NVTA) Frequently Asked Questions

What is Invitae's stock symbol?

Invitae trades on the New York Stock Exchange (NYSE) under the ticker symbol "NVTA."

How were Invitae's earnings last quarter?

Invitae (NYSE:NVTA) announced its earnings results on Wednesday, May, 9th. The medical research company reported ($0.66) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.61) by $0.05. The medical research company earned $27.67 million during the quarter, compared to the consensus estimate of $26.86 million. Invitae had a negative net margin of 154.96% and a negative return on equity of 127.38%. The business's quarterly revenue was up 167.6% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.64) EPS. View Invitae's Earnings History.

When is Invitae's next earnings date?

Invitae is scheduled to release their next quarterly earnings announcement on Monday, August, 6th 2018. View Earnings Estimates for Invitae.

What price target have analysts set for NVTA?

4 Wall Street analysts have issued 12 month price objectives for Invitae's shares. Their predictions range from $9.00 to $15.00. On average, they expect Invitae's stock price to reach $11.00 in the next year. View Analyst Ratings for Invitae.

Who are some of Invitae's key competitors?

Who are Invitae's key executives?

Invitae's management team includes the folowing people:
  • Dr. Randal W. Scott, Exec. Chairman (Age 60)
  • Dr. Sean E. George, Co-Founder, Pres, CEO & Director (Age 44)
  • Dr. Robert L. Nussbaum, Chief Medical Officer (Age 68)
  • Ms. Shelly D. Guyer, Chief Financial Officer (Age 58)
  • Mr. Lee Bendekgey, Chief Operating Officer (Age 60)

When did Invitae IPO?

(NVTA) raised $76 million in an initial public offering on Thursday, February 12th 2015. The company issued 5,400,000 shares at a price of $13.00-$15.00 per share. J.P. Morgan served as the underwriter for the IPO and Cowen and Company and Leerink Partners were co-managers.

Has Invitae been receiving favorable news coverage?

Media coverage about NVTA stock has trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Invitae earned a coverage optimism score of 0.16 on Accern's scale. They also gave news headlines about the medical research company an impact score of 46.98 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Who are Invitae's major shareholders?

Invitae's stock is owned by many different of institutional and retail investors. Top institutional investors include ARK INVESTMENT MANAGEMENT LLC (10.84%), WELLINGTON MANAGEMENT PORTFOLIOS (DUBLIN) PUBLIC LTD COMPANY (5.23%), BlackRock Inc. (5.15%), Redmile Group LLC (3.18%), Rock Springs Capital Management LP (2.08%) and CVI Holdings LLC (0.67%). Company insiders that own Invitae stock include Bros Advisors Lp Baker, E Lee Bendekgey, Geoffrey Crouse, Katherine Stueland, Patty Dumond, Randal W Scott, Robert L Nussbaum, Sean E George, Shelly D Guyer and Thomas Brida. View Institutional Ownership Trends for Invitae.

Which institutional investors are selling Invitae stock?

NVTA stock was sold by a variety of institutional investors in the last quarter, including Millennium Management LLC, Redmile Group LLC and Schwab Charles Investment Management Inc.. Company insiders that have sold Invitae company stock in the last year include E Lee Bendekgey, Katherine Stueland, Patty Dumond, Robert L Nussbaum, Sean E George, Shelly D Guyer and Thomas Brida. View Insider Buying and Selling for Invitae.

Which institutional investors are buying Invitae stock?

NVTA stock was purchased by a variety of institutional investors in the last quarter, including CVI Holdings LLC, BlackRock Inc., Victory Capital Management Inc., Rock Springs Capital Management LP, Blair William & Co. IL, Dimensional Fund Advisors LP, Gamco Investors INC. ET AL and Teton Advisors Inc.. Company insiders that have bought Invitae stock in the last two years include Bros Advisors Lp Baker, Geoffrey Crouse and Randal W Scott. View Insider Buying and Selling for Invitae.

How do I buy shares of Invitae?

Shares of NVTA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Invitae's stock price today?

One share of NVTA stock can currently be purchased for approximately $7.63.

How big of a company is Invitae?

Invitae has a market capitalization of $486.56 million and generates $68.22 million in revenue each year. The medical research company earns $-123,380,000.00 in net income (profit) each year or ($2.65) on an earnings per share basis. Invitae employs 594 workers across the globe.

How can I contact Invitae?

Invitae's mailing address is 1400 16th Street, SAN FRANCISCO CA, 94103. The medical research company can be reached via phone at 415-374-7782 or via email at [email protected]


MarketBeat Community Rating for Invitae (NVTA)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  165 (Vote Outperform)
Underperform Votes:  184 (Vote Underperform)
Total Votes:  349
MarketBeat's community ratings are surveys of what our community members think about Invitae and other stocks. Vote "Outperform" if you believe NVTA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVTA will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Invitae (NYSE:NVTA) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Invitae in the last 12 months. Their average twelve-month price target is $11.00, suggesting that the stock has a possible upside of 44.17%. The high price target for NVTA is $15.00 and the low price target for NVTA is $9.00. There are currently 4 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $11.00$11.00$11.00$14.3333
Price Target Upside: 44.17% upside90.97% upside90.97% upside58.03% upside

Invitae (NYSE:NVTA) Consensus Price Target History

Price Target History for Invitae (NYSE:NVTA)

Invitae (NYSE:NVTA) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/13/2018JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$13.00 ➝ $9.00HighView Rating Details
2/13/2018BenchmarkLower Price TargetBuy ➝ Buy$11.00 ➝ $10.00HighView Rating Details
1/16/2018Leerink SwannLower Price TargetOutperform ➝ Outperform$12.00 ➝ $10.00HighView Rating Details
1/5/2018Ladenburg ThalmannInitiated CoverageBuy ➝ Buy$15.00HighView Rating Details
(Data available from 5/23/2016 forward)

Earnings

Invitae (NYSE:NVTA) Earnings History and Estimates Chart

Earnings by Quarter for Invitae (NYSE:NVTA)

Invitae (NYSE:NVTA) Earnings Estimates

2018 EPS Consensus Estimate: ($2.11)
2019 EPS Consensus Estimate: ($1.43)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182($0.63)($0.59)($0.61)
Q2 20182($0.65)($0.53)($0.59)
Q3 20182($0.54)($0.47)($0.51)
Q4 20182($0.41)($0.40)($0.41)
Q1 20192($0.52)($0.35)($0.44)
Q2 20192($0.47)($0.35)($0.41)
Q3 20192($0.42)($0.26)($0.34)
Q4 20192($0.36)($0.12)($0.24)

Invitae (NYSE NVTA) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/6/2018        
5/9/2018Q1 2018($0.61)($0.66)$26.86 million$27.67 millionViewN/AView Earnings Details
2/12/2018Q4 2017($0.61)($0.78)$24.18 million$25.40 millionViewListenView Earnings Details
11/6/2017Q3 2017($0.55)($0.57)$20.59 million$18.15 millionViewN/AView Earnings Details
8/7/20176/30/2017($0.64)($0.66)$13.31 million$14.34 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.68)($0.64)$10.90 million$10.34 millionViewListenView Earnings Details
2/13/2017Q416($0.73)($0.69)$8.82 million$9.20 millionViewN/AView Earnings Details
11/7/2016Q316($0.72)($0.77)$7.50 million$6.30 millionViewListenView Earnings Details
8/8/2016Q216($0.76)($0.77)$5.81 million$5.60 millionViewN/AView Earnings Details
5/9/2016Q116($0.76)($0.80)$4.38 million$4.00 millionViewN/AView Earnings Details
2/9/2016Q415($0.72)($0.76)$2.92 million$3.20 millionViewN/AView Earnings Details
11/5/2015Q315($0.70)($0.71)$2.55 million$2.19 millionViewN/AView Earnings Details
8/6/2015Q215($0.55)($0.76)$1.67 million$1.80 millionViewN/AView Earnings Details
5/12/2015Q115($0.51)($1.09)$1.07 million$1.23 millionViewListenView Earnings Details
3/10/2015Q4 2014($16.75)$0.88 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Invitae (NYSE:NVTA) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Invitae (NYSE NVTA) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 8.70%
Institutional Ownership Percentage: 69.79%
Insider Trading History for Invitae (NYSE:NVTA)
Institutional Ownership by Quarter for Invitae (NYSE:NVTA)

Invitae (NYSE NVTA) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/15/2018E Lee BendekgeyCOOSell6,388$6.96$44,460.4852,396View SEC Filing  
5/15/2018Robert L. NussbaumInsiderSell6,702$6.96$46,645.92View SEC Filing  
5/15/2018Sean E. GeorgeCEOSell20,311$6.96$141,364.56View SEC Filing  
5/15/2018Shelly D GuyerCFOSell5,135$6.96$35,739.6039,865View SEC Filing  
5/15/2018Thomas BridaGeneral CounselSell1,979$6.96$13,773.84View SEC Filing  
4/2/2018Randal W ScottInsiderBuy44,444$4.50$199,998.00View SEC Filing  
3/28/2018Bros. Advisors Lp BakerMajor ShareholderBuy1,111,111$4.50$4,999,999.50View SEC Filing  
10/10/2017Patty DumondVPSell2,497$10.00$24,970.00View SEC Filing  
10/9/2017Patty DumondVPSell1,882$10.00$18,820.0052,783View SEC Filing  
9/12/2017Katherine StuelandInsiderSell612$9.40$5,752.8058,570View SEC Filing  
2/16/2017Thomas BridaGeneral CounselSell766$9.69$7,422.5424,720View SEC Filing  
2/15/2017E Lee BendekgeyCFOSell2,098$9.59$20,119.8260,882View SEC Filing  
2/15/2017Patty DumondVPSell1,264$9.55$12,071.2055,929View SEC Filing  
2/15/2017Robert L NussbaumInsiderSell1,686$9.53$16,067.5862,823View SEC Filing  
2/15/2017Thomas BridaGeneral CounselSell794$9.54$7,574.7626,280View SEC Filing  
11/22/2016Randal W ScottChairmanBuy66,666$6.00$399,996.003,506,225View SEC Filing  
11/18/2016Geoffrey CrouseDirectorBuy15,000$6.25$93,750.0034,259View SEC Filing  
11/17/2016Bros. Advisors Lp BakerMajor ShareholderBuy733,333$6.00$4,399,998.00View SEC Filing  
9/16/2016Patty DumondVPSell1,000$8.00$8,000.009,812View SEC Filing  
8/15/2016Patty DumondVPSell1,000$8.81$8,810.009,812View SEC Filing  
7/14/2016Patty DumondVPSell1,000$8.79$8,790.009,812View SEC Filing  
6/16/2016Patty DumondVPSell1,000$8.00$8,000.009,812View SEC Filing  
5/17/2016Patty DumondVPSell3,221$8.47$27,281.8712,033View SEC Filing  
4/14/2016Patty DumondVPSell1,000$10.50$10,500.009,812View SEC Filing  
2/22/2016Lisa AldersonInsiderSell7,500$7.64$57,300.0031,819View SEC Filing  
2/11/2016Sean E GeorgeCOOBuy16,950$6.16$104,412.00235,408View SEC Filing  
2/18/2015James E FlynnInsiderBuy175,000$16.00$2,800,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Invitae (NYSE NVTA) News Headlines

Source:
DateHeadline
Why This Genetics Stock Could Be a Gold Mine for Growth InvestorsWhy This Genetics Stock Could Be a Gold Mine for Growth Investors
finance.yahoo.com - May 18 at 10:20 AM
Form 4 Invitae Corp For: May 15 Filed by: Nussbaum Robert LForm 4 Invitae Corp For: May 15 Filed by: Nussbaum Robert L
www.streetinsider.com - May 17 at 4:49 PM
Form 4 Invitae Corp For: May 15 Filed by: George Sean EForm 4 Invitae Corp For: May 15 Filed by: George Sean E
www.streetinsider.com - May 17 at 9:09 AM
Sean E. George Sells 20,311 Shares of Invitae (NVTA) StockSean E. George Sells 20,311 Shares of Invitae (NVTA) Stock
www.americanbankingnews.com - May 16 at 10:29 PM
Invitae (NVTA) Insider Sells $46,645.92 in StockInvitae (NVTA) Insider Sells $46,645.92 in Stock
www.americanbankingnews.com - May 16 at 10:28 PM
Insider Selling: Invitae (NVTA) COO Sells 6,388 Shares of StockInsider Selling: Invitae (NVTA) COO Sells 6,388 Shares of Stock
www.americanbankingnews.com - May 16 at 10:28 PM
Shelly D. Guyer Sells 5,135 Shares of Invitae (NVTA) StockShelly D. Guyer Sells 5,135 Shares of Invitae (NVTA) Stock
www.americanbankingnews.com - May 16 at 10:28 PM
Thomas Brida Sells 1,979 Shares of Invitae (NVTA) StockThomas Brida Sells 1,979 Shares of Invitae (NVTA) Stock
www.americanbankingnews.com - May 16 at 10:28 PM
Invitae Beats And Raises - Upside Is HereInvitae Beats And Raises - Upside Is Here
seekingalpha.com - May 16 at 4:58 PM
Invitae (NVTA) Cut to "Hold" at Zacks Investment ResearchInvitae (NVTA) Cut to "Hold" at Zacks Investment Research
www.americanbankingnews.com - May 15 at 11:51 AM
Edited Transcript of NVTA earnings conference call or presentation 9-May-18 8:30pm GMTEdited Transcript of NVTA earnings conference call or presentation 9-May-18 8:30pm GMT
finance.yahoo.com - May 14 at 4:51 PM
Invitae (NVTA) to Post Q1 2019 Earnings of ($0.52) Per Share, William Blair ForecastsInvitae (NVTA) to Post Q1 2019 Earnings of ($0.52) Per Share, William Blair Forecasts
www.americanbankingnews.com - May 14 at 4:11 AM
Q2 2018 EPS Estimates for Invitae (NVTA) Decreased by AnalystQ2 2018 EPS Estimates for Invitae (NVTA) Decreased by Analyst
www.americanbankingnews.com - May 14 at 2:00 AM
 Analysts Expect Invitae (NVTA) Will Announce Quarterly Sales of $29.40 Million Analysts Expect Invitae (NVTA) Will Announce Quarterly Sales of $29.40 Million
www.americanbankingnews.com - May 13 at 3:48 AM
 Brokerages Anticipate Invitae (NVTA) Will Announce Earnings of -$0.60 Per Share Brokerages Anticipate Invitae (NVTA) Will Announce Earnings of -$0.60 Per Share
www.americanbankingnews.com - May 11 at 1:20 PM
Heres Why Invitae Rose as Much as 13.9% TodayHere's Why Invitae Rose as Much as 13.9% Today
www.fool.com - May 11 at 10:00 AM
Here's Why Invitae Rose as Much as 13.9% TodayHere's Why Invitae Rose as Much as 13.9% Today
finance.yahoo.com - May 10 at 4:52 PM
Invitae (NVTA) Given Average Recommendation of "Buy" by AnalystsInvitae (NVTA) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - May 10 at 4:04 PM
Invitaes (NVTA) CEO Sean George on Q1 2018 Results - Earnings Call TranscriptInvitae's (NVTA) CEO Sean George on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 10 at 9:14 AM
Invitae: 1Q Earnings SnapshotInvitae: 1Q Earnings Snapshot
finance.yahoo.com - May 10 at 9:14 AM
Invitae (NVTA) Posts  Earnings Results, Misses Estimates By $0.05 EPSInvitae (NVTA) Posts Earnings Results, Misses Estimates By $0.05 EPS
www.americanbankingnews.com - May 10 at 12:15 AM
BRIEF-Invitae Reports Q1 Loss Per Share $0.66BRIEF-Invitae Reports Q1 Loss Per Share $0.66
www.reuters.com - May 9 at 4:52 PM
Invitae Reports 169% Revenue Growth Driven by 150% Growth in Volume in First Quarter 2018Invitae Reports 169% Revenue Growth Driven by 150% Growth in Volume in First Quarter 2018
finance.yahoo.com - May 9 at 4:52 PM
BRIEF-Sarepta And Invitae Expand Partnership To Advance Clinical Research In Duchenne Muscular DystrophyBRIEF-Sarepta And Invitae Expand Partnership To Advance Clinical Research In Duchenne Muscular Dystrophy
www.reuters.com - May 7 at 9:47 AM
Play Stocks With Rising P/E to Enjoy Solid GainsPlay Stocks With Rising P/E to Enjoy Solid Gains
finance.yahoo.com - May 7 at 9:47 AM
Market Trends Toward New Normal in LRAD, Xencor, QuinStreet, Old Second, WesBanco, and Invitae — Emerging ...Market Trends Toward New Normal in LRAD, Xencor, QuinStreet, Old Second, WesBanco, and Invitae — Emerging ...
www.nasdaq.com - May 4 at 8:56 AM
Contrasting Invitae (NVTA) and Its PeersContrasting Invitae (NVTA) and Its Peers
www.americanbankingnews.com - May 2 at 10:00 AM
Invitae (NVTA) Scheduled to Post Quarterly Earnings on WednesdayInvitae (NVTA) Scheduled to Post Quarterly Earnings on Wednesday
www.americanbankingnews.com - May 2 at 6:58 AM
Head to Head Analysis: Invitae (NVTA) vs. Its RivalsHead to Head Analysis: Invitae (NVTA) vs. Its Rivals
www.americanbankingnews.com - May 1 at 11:22 AM
Financial Comparison: Invitae (NVTA) vs. Its PeersFinancial Comparison: Invitae (NVTA) vs. Its Peers
www.americanbankingnews.com - May 1 at 8:48 AM
Contrasting Invitae (NVTA) and The CompetitionContrasting Invitae (NVTA) and The Competition
www.americanbankingnews.com - April 29 at 5:25 PM
Comparing Invitae (NVTA) and The CompetitionComparing Invitae (NVTA) and The Competition
www.americanbankingnews.com - April 29 at 11:14 AM
Invitae (NVTA) & The Competition Head to Head SurveyInvitae (NVTA) & The Competition Head to Head Survey
www.americanbankingnews.com - April 29 at 3:08 AM
Invitae (NVTA) and The Competition Financial ContrastInvitae (NVTA) and The Competition Financial Contrast
www.americanbankingnews.com - April 28 at 5:20 AM
Invitae Announces New Program to Offer Genetic Testing to Aid Diagnosis of Spinal Muscular Atrophy (SMA)Invitae Announces New Program to Offer Genetic Testing to Aid Diagnosis of Spinal Muscular Atrophy (SMA)
finance.yahoo.com - April 27 at 9:26 AM
Analyzing Invitae (NVTA) & Its RivalsAnalyzing Invitae (NVTA) & Its Rivals
www.americanbankingnews.com - April 27 at 3:32 AM
$25.82 Million in Sales Expected for Invitae Co. (NVTA) This Quarter$25.82 Million in Sales Expected for Invitae Co. (NVTA) This Quarter
www.americanbankingnews.com - April 26 at 5:46 AM
Head-To-Head Comparison: Invitae (NVTA) and The CompetitionHead-To-Head Comparison: Invitae (NVTA) and The Competition
www.americanbankingnews.com - April 26 at 3:16 AM
Invitae to Announce First Quarter 2018 Financial Results on May 9, 2018Invitae to Announce First Quarter 2018 Financial Results on May 9, 2018
finance.yahoo.com - April 25 at 9:27 AM
Invitae Co. (NVTA) Expected to Announce Earnings of -$0.64 Per ShareInvitae Co. (NVTA) Expected to Announce Earnings of -$0.64 Per Share
www.americanbankingnews.com - April 24 at 3:20 AM
Comparing Invitae (NVTA) and Its RivalsComparing Invitae (NVTA) and Its Rivals
www.americanbankingnews.com - April 21 at 1:04 AM
Invitae (NVTA) Raised to "Strong-Buy" at Zacks Investment ResearchInvitae (NVTA) Raised to "Strong-Buy" at Zacks Investment Research
www.americanbankingnews.com - April 18 at 10:04 AM
Financial Review: Invitae (NVTA) vs. Its RivalsFinancial Review: Invitae (NVTA) vs. Its Rivals
www.americanbankingnews.com - April 17 at 11:10 PM
Zacks Investment Research Downgrades Invitae (NVTA) to SellZacks Investment Research Downgrades Invitae (NVTA) to Sell
www.americanbankingnews.com - April 17 at 9:15 PM
Invitae (NVTA) vs. Its Competitors Financial SurveyInvitae (NVTA) vs. Its Competitors Financial Survey
www.americanbankingnews.com - April 16 at 7:15 AM
Invitae Co. (NVTA) Given Consensus Rating of "Hold" by BrokeragesInvitae Co. (NVTA) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - April 15 at 1:27 PM
Invitae (NVTA) Cut to Sell at BidaskClubInvitae (NVTA) Cut to Sell at BidaskClub
www.americanbankingnews.com - April 15 at 12:35 PM
Invitae (NVTA) and Its Peers Head-To-Head ContrastInvitae (NVTA) and Its Peers Head-To-Head Contrast
www.americanbankingnews.com - April 14 at 7:43 AM
BidaskClub Upgrades Invitae (NVTA) to "Hold"BidaskClub Upgrades Invitae (NVTA) to "Hold"
www.americanbankingnews.com - April 13 at 4:23 PM
Analyzing Invitae (NVTA) & Its CompetitorsAnalyzing Invitae (NVTA) & Its Competitors
www.americanbankingnews.com - April 13 at 8:53 AM

SEC Filings

Invitae (NYSE:NVTA) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Invitae (NYSE:NVTA) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Invitae (NYSE NVTA) Stock Chart for Wednesday, May, 23, 2018

Loading chart…

This page was last updated on 5/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.